Singapore markets open in 5 hours 52 minutes
Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,046.41 -25.22 (-0.50%) Dow
38,066.62 -394.30 (-1.03%) Nasdaq
15,602.23 -110.52 (-0.70%) Bitcoin USD
64,731.88 +658.38 (+1.03%) CMC Crypto 200
1,394.54 +11.96 (+0.87%)
Prothena Corporation plc (PRTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:08PM EDT. Market open.
| Previous close | 20.56 |
| Open | 20.26 |
| Bid | 20.59 x 100 |
| Ask | 20.67 x 100 |
| Day's range | 19.65 - 20.67 |
| 52-week range | 19.65 - 79.65 |
| Volume | |
| Avg. volume | 657,135 |
| Market cap | 1.108B |
| Beta (5Y monthly) | 0.24 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.76 |
| Earnings date | 29 Apr 2024 - 03 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 66.77 |
ZacksEarnings Preview: Prothena (PRTA) Q1 Earnings Expected to Decline
Prothena (PRTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Business WireProthena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
ZacksCHMP to Delay Nod on Biogen (BIIB), Eisai's Alzheimer's Drug
Per Biogen (BIIB)/Eisai, the delay in CHMP recommendation for lecanemab is entirely related to procedural reasons at the EMA and is not related to the companies' regulatory filing.
© 2024 Yahoo. All rights reserved.